AAAAAA

   
Results: 1-21 |
Results: 21
Predicting analysis times in randomized clinical trials
Authors: Bagiella, E Heitjan, DF
Citation: E. Bagiella et Df. Heitjan, Predicting analysis times in randomized clinical trials, STAT MED, 20(14), 2001, pp. 2055-2063
Long-term use of a left ventricular assist device for end-stage heart failure
Authors: Rose, EA Gelijns, AC Moskowitz, AJ Heitjan, DF Stevenson, LW Dembitsky, W Long, JW Ascheim, DD Tierney, AR Levitan, RG Watson, JT Meier, P
Citation: Ea. Rose et al., Long-term use of a left ventricular assist device for end-stage heart failure, N ENG J MED, 345(20), 2001, pp. 1435-1443
Estimating the effect of an intensive surveillance program on stage of breast carcinoma at diagnosis - A propensity score analysis
Authors: Mitra, N Schnabel, FR Neugut, AI Heitjan, DF
Citation: N. Mitra et al., Estimating the effect of an intensive surveillance program on stage of breast carcinoma at diagnosis - A propensity score analysis, CANCER, 91(9), 2001, pp. 1709-1715
Decision analysis of tamoxifen for the prevention of invasive breast cancer
Authors: Grann, VR Sundararajan, V Jacobson, JS Whang, W Heitjan, DF Antman, KH Neugut, AI
Citation: Vr. Grann et al., Decision analysis of tamoxifen for the prevention of invasive breast cancer, CANCER J, 6(3), 2000, pp. 169-178
Prevention with tamoxifen or other hormones versus prophylactic surgery inBRCA1/2-positive women: A decision analysis
Authors: Grann, VR Jacobson, JS Whang, W Hershman, D Heitjan, DF Antman, KH Neugut, AI
Citation: Vr. Grann et al., Prevention with tamoxifen or other hormones versus prophylactic surgery inBRCA1/2-positive women: A decision analysis, CA J SCI AM, 6(1), 2000, pp. 13-20
Fieller's method and net health benefits
Authors: Heitjan, DF
Citation: Df. Heitjan, Fieller's method and net health benefits, HEALTH ECON, 9(4), 2000, pp. 327-335
Mixed-effects models in psychophysiology
Authors: Bagiella, E Sloan, RP Heitjan, DF
Citation: E. Bagiella et al., Mixed-effects models in psychophysiology, PSYCHOPHYSL, 37(1), 2000, pp. 13-20
Ascertainment and anticipation in family studies
Authors: Hoh, J Heitjan, DF Merette, C Ott, J
Citation: J. Hoh et al., Ascertainment and anticipation in family studies, HUMAN HERED, 51(1-2), 2000, pp. 23-26
A reliability studs for evaluating information extraction from radiology reports
Authors: Hripcsak, G Kuperman, GJ Friedman, C Heitjan, DF
Citation: G. Hripcsak et al., A reliability studs for evaluating information extraction from radiology reports, J AM MED IN, 6(2), 1999, pp. 143-150
Bayesian estimation of cost-effectiveness ratios from clinical trials
Authors: Heitjan, DF Moskowitz, AJ Whang, W
Citation: Df. Heitjan et al., Bayesian estimation of cost-effectiveness ratios from clinical trials, HEALTH ECON, 8(3), 1999, pp. 191-201
Re-evaluation of benefits of BRCA1/2 testing - Reply
Authors: Grann, VR Whang, W Jacobson, JS Heitjan, DF Antman, KH Neugut, AI
Citation: Vr. Grann et al., Re-evaluation of benefits of BRCA1/2 testing - Reply, J CL ONCOL, 17(6), 1999, pp. 1962-1962
Benefits and costs of screening Ashkenazi Jewish women for BRCA1 and BRCA2
Authors: Grann, VR Whang, W Jacobson, JS Heitjan, DF Antman, KH Neugut, AI
Citation: Vr. Grann et al., Benefits and costs of screening Ashkenazi Jewish women for BRCA1 and BRCA2, J CL ONCOL, 17(2), 1999, pp. 494-500
Ignorability and bias in clinical trials
Authors: Heitjan, DF
Citation: Df. Heitjan, Ignorability and bias in clinical trials, STAT MED, 18(17-18), 1999, pp. 2421-2434
Problems with interval estimates of the incremental cost-effectiveness ratio
Authors: Heitjan, DF Moskowitz, AJ Whang, W
Citation: Df. Heitjan et al., Problems with interval estimates of the incremental cost-effectiveness ratio, MED DECIS M, 19(1), 1999, pp. 9-15
Probabilistic sensitivity analysis in cost-effectiveness - An application from a study of vaccination against pneumococcal bacteremia in the elderly
Authors: Whang, W Sisk, JE Heitjan, DF Moskowitz, AJ
Citation: W. Whang et al., Probabilistic sensitivity analysis in cost-effectiveness - An application from a study of vaccination against pneumococcal bacteremia in the elderly, INT J TE A, 15(3), 1999, pp. 563-572
Causal inference in a clinical trial: A comparative example
Authors: Heitjan, DF
Citation: Df. Heitjan, Causal inference in a clinical trial: A comparative example, CONTR CL TR, 20(4), 1999, pp. 309-318
High-dose chemotherapy for breast cancer
Authors: Antman, KH Heitjan, DF Hortobagyi, GN
Citation: Kh. Antman et al., High-dose chemotherapy for breast cancer, J AM MED A, 282(18), 1999, pp. 1701-1703
Volume-outcome relationships in cardiovascular operations: New York State,1990-1995
Authors: Sollano, JA Gelijns, AC Moskowitz, AJ Heitjan, DF Cullinane, S Saha, T Chen, JM Roohan, PJ Reemtsma, K Shields, EP
Citation: Ja. Sollano et al., Volume-outcome relationships in cardiovascular operations: New York State,1990-1995, J THOR SURG, 117(3), 1999, pp. 419-430
Geographic variations in the rates of operative procedures involving the shoulder, including total shoulder replacement, humeral head replacement, and rotator cuff repair
Authors: Vitale, MG Krant, JJ Gelijns, AC Heitjan, DF Arons, RR Bigliani, LU Flatow, EL
Citation: Mg. Vitale et al., Geographic variations in the rates of operative procedures involving the shoulder, including total shoulder replacement, humeral head replacement, and rotator cuff repair, J BONE-AM V, 81A(6), 1999, pp. 763-772
The REMATCH trial: Rationale, design, and end points
Authors: Rose, EA Moskowitz, AJ Packer, M Sollano, JA Williams, DL Tierney, AR Heitjan, DF Meier, P Ascheim, DD Levitan, RG Weinberg, AD Stevenson, LW Shapiro, PA Lazar, RM Watson, JT Goldstein, DJ Gelijns, AC
Citation: Ea. Rose et al., The REMATCH trial: Rationale, design, and end points, ANN THORAC, 67(3), 1999, pp. 723-730
Growth inhibition induced by Ro 31-8220 and calphostin C in human glioblastoma cell lines is associated with apoptosis and inhibition of CDC2 kinase
Authors: Begemann, M Kashimawo, SA Lunn, RM Delohery, T Choi, YJA Kim, S Heitjan, DF Santella, RM Schiff, PB Bruce, JN Weinstein, IB
Citation: M. Begemann et al., Growth inhibition induced by Ro 31-8220 and calphostin C in human glioblastoma cell lines is associated with apoptosis and inhibition of CDC2 kinase, ANTICANC R, 18(5A), 1998, pp. 3139-3152
Risultati: 1-21 |